Oral lesions in patients with severe COVID-19 in the National Institute of Respiratory Diseases in Mexico: Case series
- PMID: 37650015
- PMCID: PMC10462920
- DOI: 10.34172/joddd.2023.37072
Oral lesions in patients with severe COVID-19 in the National Institute of Respiratory Diseases in Mexico: Case series
Abstract
Oral manifestations in patients with COVID-19 have already been reported in the literature. Determining whether the oral manifestations in these cases are directly related to SARS-CoV-2 infection or not has been challenging for both clinicians and researchers, although at present it has not been possible to prove. There are several possible causes for the development of the oral lesions in patients with COVID-19, among them are, opportunistic infections, drug reactions, iatrogenic and those directly related to viral infection. The present work describes the main characteristics of 10 severe COVID-19 hospitalized patients with oral manifestations. By analyzing the characteristics of the reported patients, and what is published in the literature, we conclude that for this series of cases the manifestations are not directly related to SARS-CoV-2, however, it is a possibility that should be considered for all patients.
Keywords: COVID-19; Oral lesions; SARS-CoV-2; Severe.
©2023 The Author(s).
Conflict of interest statement
The authors declare that they have no conflict of interest in this work.
Figures
Similar articles
-
COVID-19 and Its Repercussions on Oral Health: A Review.Medicina (Kaunas). 2021 Nov 1;57(11):1189. doi: 10.3390/medicina57111189. Medicina (Kaunas). 2021. PMID: 34833407 Free PMC article. Review.
-
Is SARS-CoV-2 an Etiologic Agent or Predisposing Factor for Oral Lesions in COVID-19 Patients? A Concise Review of Reported Cases in the Literature.Int J Dent. 2021 May 18;2021:6648082. doi: 10.1155/2021/6648082. eCollection 2021. Int J Dent. 2021. PMID: 34054961 Free PMC article. Review.
-
Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial.Trials. 2020 Oct 28;21(1):897. doi: 10.1186/s13063-020-04819-9. Trials. 2020. PMID: 33115543 Free PMC article.
-
Oral Manifestations of COVID-19 in Hospitalized Patients: A Systematic Review.Int J Environ Res Public Health. 2021 Nov 27;18(23):12511. doi: 10.3390/ijerph182312511. Int J Environ Res Public Health. 2021. PMID: 34886241 Free PMC article.
-
Pathogenesis-directed therapy of 2019 novel coronavirus disease.J Med Virol. 2021 Mar;93(3):1320-1342. doi: 10.1002/jmv.26610. Epub 2020 Nov 10. J Med Virol. 2021. PMID: 33073355 Review.
Cited by
-
Unveiling the Oral Lesions, Dysgeusia and Osteonecrosis Related to COVID-19: A Comprehensive Systematic Review.J Clin Med. 2025 Feb 14;14(4):1267. doi: 10.3390/jcm14041267. J Clin Med. 2025. PMID: 40004799 Free PMC article. Review.
-
Painful ulcerations associated with COVID-19 in an adolescent patient: a case report.Front Dent Med. 2024 Aug 2;5:1412439. doi: 10.3389/fdmed.2024.1412439. eCollection 2024. Front Dent Med. 2024. PMID: 39917675 Free PMC article.
-
Awareness of undergraduate dental students, interns, and freshly graduated dentists about oral manifestation associated with COVID-19.BMC Oral Health. 2023 Dec 9;23(1):990. doi: 10.1186/s12903-023-03666-9. BMC Oral Health. 2023. PMID: 38071326 Free PMC article.
References
-
- Lechien JR, Chiesa-Estomba CM, De Siati DR, Horoi M, Le Bon SD, Rodriguez A, et al. Olfactory and gustatory dysfunctions as a clinical presentation of mild-to-moderate forms of the coronavirus disease (COVID-19): a multicenter European study. Eur Arch Otorhinolaryngol. 2020;277(8):2251–61. doi: 10.1007/s00405-020-05965-1. - DOI - PMC - PubMed
Publication types
LinkOut - more resources
Full Text Sources
Miscellaneous